+ All Categories
Home > Documents > Opioid Use and Misuse: Current Perspectives

Opioid Use and Misuse: Current Perspectives

Date post: 20-Feb-2022
Category:
Upload: others
View: 3 times
Download: 0 times
Share this document with a friend
48
Opioid Use and Misuse: Current Perspectives John Sorboro, MD, ABPN Diplomat, American Society of Addiction Medicine Chief Medical Officer Behavioral Health, HSAG June 13, 2019
Transcript
Page 1: Opioid Use and Misuse: Current Perspectives

Opioid Use and Misuse: Current Perspectives

John Sorboro, MD, ABPNDiplomat, American Society of Addiction Medicine

Chief Medical Officer Behavioral Health, HSAGJune 13, 2019

Page 2: Opioid Use and Misuse: Current Perspectives

Transition SlideUsed for changing topics

Page 3: Opioid Use and Misuse: Current Perspectives

How Drug Overdose Mortality Has Changed

3

Page 4: Opioid Use and Misuse: Current Perspectives

How Drug Overdose Mortality Has Changed

4

Page 5: Opioid Use and Misuse: Current Perspectives

Deaths in 2017

NOTES: Deaths are classified using the International Classification of Diseases, 10th Revision. Drug-poisoning (overdose) deaths are identified using underlying cause-of-death codes X40–X44, X60–X64, X85, and Y10–Y14.

Source: NCHS, National Vital Statistics System, Mortality.5

Page 6: Opioid Use and Misuse: Current Perspectives

Prescription Opioid Deaths

6

Page 7: Opioid Use and Misuse: Current Perspectives

Heroin Has Not Gone Away

7

Page 8: Opioid Use and Misuse: Current Perspectives

It’s Not Just Opioids!

8

Page 9: Opioid Use and Misuse: Current Perspectives

Amphetamine Deaths

9

Page 10: Opioid Use and Misuse: Current Perspectives

A Deadly Combination

10

Page 11: Opioid Use and Misuse: Current Perspectives

Not So Antidepressant

11

Page 12: Opioid Use and Misuse: Current Perspectives

The Top 10

1) Fentanyl2) Heroin3) Cocaine4) Methamphetamine5) Alprazolam6) Oxycodone7) Morphine8) Methadone9) Hydrocodone10) Diazepam

https://www.cdc.gov/nchs/data/nvsr/nvsr67/nvsr67_09-508.pdf

12

Page 13: Opioid Use and Misuse: Current Perspectives

Where Are We Heading With Benzos?

13

Page 14: Opioid Use and Misuse: Current Perspectives

Changes in Benzodiazepine Prescribing

• National Ambulatory Medical Care Survey (NAMCS) from January 1, 2003, through December 31, 2015.

• Looked at eight commonly prescribed Benzodiazepines• The benzodiazepine visit rate increased from 3.8% to 7.4%.• 127% increase in the absolute number of benzodiazepine

visits occurred.• The unadjusted benzodiazepine visit rate did not change

among visits to psychiatrists, but increased among visits to primary care, surgeons and medical specialists.

• Largest increase: back and chronic pain and instances in which we were unable to attribute the benzodiazepine to a particular indication.

14

Page 15: Opioid Use and Misuse: Current Perspectives

Benzodiazepine and Opioid Prescriptions, 2015

• Benzodiazepines and opioids co-prescribed • 19.2% of opioid visits got a BNZ• 26.4% of BNZ visits got an opioid• Rate at which benzodiazepine and opioid

prescriptions were noted in a single visit quadrupled from 0.5% to 2.0%

15 https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2722576

Page 16: Opioid Use and Misuse: Current Perspectives

Prescribe?BNZ?

16

Opioid?Muscle

Relaxer?

Page 17: Opioid Use and Misuse: Current Perspectives

Benzodiazepines Over Time

https://jamanetwork.com/journals/jamapsychiatry/fullarticle/201995517

Page 18: Opioid Use and Misuse: Current Perspectives

Why Is This Happening?

18

Page 19: Opioid Use and Misuse: Current Perspectives

Such a Pretty Flower!

19

Page 20: Opioid Use and Misuse: Current Perspectives

To This…

20

Page 21: Opioid Use and Misuse: Current Perspectives

U.S. and Europe Total Opioid Consumption: 1980–2015

21

Page 22: Opioid Use and Misuse: Current Perspectives

Opioid Prescribing

Source: National Prescription Audit (NPATM), 2012. Data from IMS. Accessed on: September 28, 2018. Available at: https://www.cdc.gov/vitalsigns/opioid-prescribing/infographic.html

This color-coded U.S. map shows the number of painkiller prescriptions per 100 people in each of the fifty states plus the District of Columbia in 2012.

22

Page 23: Opioid Use and Misuse: Current Perspectives

State Ranking of Fatal Overdoses/100,000

1. West Virginia — 49.62. Ohio — 39.23. District of Columbia — 34.74. New Hampshire — 345. Maryland — 32.217. Tennessee — 19.323. Florida — 16.329. Arizona — 13.530. Nevada — 13.331. Oklahoma — 10.2

CDC's National Center for Health Statistics23

Page 24: Opioid Use and Misuse: Current Perspectives

State Ranking of Opioid Sales: 2017

1) Tennessee 44.3kg (*17)2) Oklahoma 43.1kg (*31)3) Nevada 40.5kg (*30)8) Arizona 32.9kg (*29)14) West Virginia 30.7kg (*1)17) Florida 29.4kg (*23)31) Ohio 23.1kg (*2)51) District of Columbia 10.6kg (*3)

24

Page 25: Opioid Use and Misuse: Current Perspectives

Largest Reductions in Opioid Sales: 2010–2017

1) Florida 61%4) West Virginia 42%5) Nevada 38%6) Ohio 37%8) Tennessee 36%18) District of Columbia 25%

25

Page 26: Opioid Use and Misuse: Current Perspectives

Number of Opioid-Related Deaths Grew 2.8 Times from 2002–2015

26 Source: National Institute on Drug Abuse. Overdose Death Rates. National Drug Overdose Deaths (Figure 1). Accessed on April 15, 2019. Available at https://d14rmgtrwzf5a.cloudfront.net/sites/default/files/national_drug_overdose_deaths_through_2017.pdf.

Page 27: Opioid Use and Misuse: Current Perspectives

What Is Killing People? Pt.1

Fatalities at 42,000 in 2016 (CDC)

Nearly double casualties in 2010; >5x 1999 figures

False narrative?

Patients addicted to doctor-prescribed opioids

Nonmedical use of prescription opioids peaked in 2012

CDC = The Centers for Disease Control & Prevention

27Source: National Institute on Drug Abuse. The National Survey on Drug Use in Health. Accessed on April 15, 2019. Available at https://www.drugabuse.gov/national-survey-drug-use-health.

Page 28: Opioid Use and Misuse: Current Perspectives

What Is Killing People? Pt.2

1. Minozzi, S., Amato, L. Development of dependence following treatment with opioid analgesics for pain relief: a systematic review. Addiction 2012 . Accessed on April 15, 2019. Available at https://onlinelibrary.wiley.com/doi/full/10.1111/j.1360-0443.2012.04005.x.

2. Volkow, N.D., McLellan, A.T. Opioid Abuse in Chronic Pain—Misconceptions and Mitigation Strategies. N Engl J Med 2016; 374:1253–1263. Accessed on April 15, 2019. Available at https://www.nejm.org/doi/full/10.1056/NEJMra1507771.

Minority of those prescribed opioids develop opioid use disorder

Diversion of many drugs is common and difficult to prevent

28

Page 29: Opioid Use and Misuse: Current Perspectives

What Is Killing People? Pt.3

Of 136K patients in ERs treated for opioid overdoses, 13% were chronic pain patients (JAMA, 2014)

Heroin and fentanyl use increases are strongly correlated with increased opioid deaths1

95% of overdose deaths are related to polypharmacy2

JAMA = Journal of the American Medical Association

291. CDC. National Vital Statistics Reports Vol. 65, No.10, December 20, 2016. Available at: https://www.cdc.gov/nchs/data/nvsr/nvsr65/nvsr65_10.pdf

Accessed on: September 28, 20182. Richard M. Fairbanks School of Public Health. Polypharmacy Among Prescription Drug Users. August 2017 Accessed on April 16, 2019. Available at

https://fsph.iupui.edu/doc/research-centers/polypharmacy-among-prescription-drug-users.pdf

Page 30: Opioid Use and Misuse: Current Perspectives

Novel Synthetic Opioids

• AH-7921• U-47700• MT-45• Butyryl-fentanyl• ???

30

Page 31: Opioid Use and Misuse: Current Perspectives

How Did We Get Here?

31

Page 32: Opioid Use and Misuse: Current Perspectives

America: The Farewell Tour…

32

Page 33: Opioid Use and Misuse: Current Perspectives

What Can We Do?

33

Page 34: Opioid Use and Misuse: Current Perspectives

“That hurts! You got 2 vital signs?”

Page 35: Opioid Use and Misuse: Current Perspectives

Is Your Pain a 1 or a 75?

35

Page 36: Opioid Use and Misuse: Current Perspectives

Movement to a Multi-Dimensional Tool

36

Page 37: Opioid Use and Misuse: Current Perspectives

Better Measurement Tools

https://www.sciencedirect.com/science/article/pii/S235264671500109X37

Page 38: Opioid Use and Misuse: Current Perspectives

You have 7 days to live and your

7 minutes are up.

Huh?

38

Page 39: Opioid Use and Misuse: Current Perspectives

Why Do We Consume so Many Prescription Drugs?

*Includes Africa, Asia, and Australia39

Page 40: Opioid Use and Misuse: Current Perspectives

How Many Should We Give? (5mg Oxycodone)

• Partial mastectomy: 5 pills• Partial mastectomy with sentinel lymph node

biopsy: 10 pills• Laparoscopic cholecystectomy: 15 pills• Laparoscopic inguinal hernia repair: 15 pills• Open inguinal hernia repair: 15 pills

https://www.uptodate.com/contents/prescription-of-opioids-for-acute-pain-in-opioid-naive-patients/abstract/1840

Page 41: Opioid Use and Misuse: Current Perspectives

Leftovers Are Not Good

• Patients used 27% of the opioids prescribed to them.

• Prescription size had the strongest association with opioid consumption after surgery

• Patients using an additional 5 pills for every 10 extra pills prescribed.

• Significant disparities between the quantity of opioids prescribed and consumed after surgery.

41

Page 42: Opioid Use and Misuse: Current Perspectives

What Is Opioid Stewardship?

• Leadership Commitment and Culture• Organizational Policies• Clinical Knowledge, Expertise and Practice• Patient and Family Education & Engagement• Tracking, Monitoring & Reporting • Accountability• Community

42

Page 43: Opioid Use and Misuse: Current Perspectives

Different Patient/Different Needs

• Opioid Naïve: Not been exposed to opioids in the past 30 days

• Opioid Exposed: History of chronic pain who have been prescribed opioids daily for long periods of time (months to years), opioid tolerant

• Opioid Use Disorder: Individuals with a history of escalating patterns of opioid use despite negative consequences in health, family work and other areas of their life.

43

Page 44: Opioid Use and Misuse: Current Perspectives

Opioid Prescriber Education

• One-hour mandatory narcotics-prescribing education program

• Postoperative opioid-prescribing guidelines(hand, sports, and foot and ankle services)

• The decrease in pills prescribed in the post-intervention group (6 procedures) amounted to 30,000 fewer opioid pills prescribed per year

• Knee arthroscopy (6), Shoulder arthroscopy (6), Hip arthroscopy (16), Hand (13–21)

44

Page 45: Opioid Use and Misuse: Current Perspectives

We Still Have Work!

https://www.cdc.gov/drugoverdose/images/vitalsigns/VS_MME-Prescribing-Graphic_508.pdf45

Page 46: Opioid Use and Misuse: Current Perspectives

Have We Evolved To Be Self-Destructive?

46

Page 47: Opioid Use and Misuse: Current Perspectives

Thank you!John Sorboro, MD, ABPN

Diplomat, American Society of Addiction MedicineChief Medical Officer Behavioral Health, HSAG

June 13, 2019

Page 48: Opioid Use and Misuse: Current Perspectives

This material was prepared by Health Services Advisory Group, Inc., the Medicare Quality Improvement Organization for Arizona, under contract with the Centers for Medicare & Medicaid Services (CMS), an agency of the

U.S. Department of Health and Human Services. The contents presented do not necessarily reflect CMS policy. Publication No. CA-11SOW-C.3-05282019-14.

CMS Disclaimer


Recommended